MediciNova Price To Book vs. Price To Sales
| MNOV Stock | USD 2.17 0.01 0.46% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.23 | 0.4 |
|
|
For MediciNova profitability analysis, we use financial ratios and fundamental drivers that measure the ability of MediciNova to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well MediciNova utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between MediciNova's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of MediciNova over time as well as its relative position and ranking within its peers.
MediciNova |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MediciNova. If investors know MediciNova will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MediciNova listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.21) | Revenue Per Share 0.02 | Return On Assets (0.1) | Return On Equity (0.13) |
The market value of MediciNova is measured differently than its book value, which is the value of MediciNova that is recorded on the company's balance sheet. Investors also form their own opinion of MediciNova's value that differs from its market value or its book value, called intrinsic value, which is MediciNova's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MediciNova's market value can be influenced by many factors that don't directly affect MediciNova's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MediciNova's value and its price as these two are different measures arrived at by different means. Investors typically determine if MediciNova is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MediciNova's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
MediciNova Price To Sales vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining MediciNova's current stock value. Our valuation model uses many indicators to compare MediciNova value to that of its competitors to determine the firm's financial worth. MediciNova is regarded fifth in price to book category among its peers. It is regarded second in price to sales category among its peers fabricating about 55.58 of Price To Sales per Price To Book. At this time, MediciNova's Price To Sales Ratio is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value MediciNova by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.MediciNova Price To Sales vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
MediciNova |
| = | 1.92 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
MediciNova |
| = | 106.43 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
MediciNova Price To Sales Comparison
MediciNova is currently under evaluation in price to sales category among its peers.
MediciNova Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in MediciNova, profitability is also one of the essential criteria for including it into their portfolios because, without profit, MediciNova will eventually generate negative long term returns. The profitability progress is the general direction of MediciNova's change in net profit over the period of time. It can combine multiple indicators of MediciNova, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -118.1 K | -124 K | |
| Operating Income | -9.9 M | -10.4 M | |
| Net Loss | -8.6 M | -9 M | |
| Income Tax Expense | 3 K | 3.2 K | |
| Income Before Tax | -8.6 M | -9 M | |
| Total Other Income Expense Net | 1.3 M | 1.4 M | |
| Net Loss | -8.6 M | -9 M | |
| Non Operating Income Net Other | 646.7 K | 679.1 K | |
| Net Loss | -12.7 M | -13.3 M | |
| Interest Income | 1.8 M | 1.9 M | |
| Net Interest Income | 1.8 M | 1.9 M | |
| Change To Netincome | 879.7 K | 835.8 K | |
| Net Loss | (0.17) | (0.18) | |
| Income Quality | 0.87 | 0.94 | |
| Net Income Per E B T | 1.00 | 0.67 |
MediciNova Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on MediciNova. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of MediciNova position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the MediciNova's important profitability drivers and their relationship over time.
Use MediciNova in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MediciNova position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MediciNova will appreciate offsetting losses from the drop in the long position's value.MediciNova Pair Trading
MediciNova Pair Trading Analysis
The ability to find closely correlated positions to MediciNova could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MediciNova when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MediciNova - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MediciNova to buy it.
The correlation of MediciNova is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MediciNova moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MediciNova moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MediciNova can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your MediciNova position
In addition to having MediciNova in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Financials Thematic Idea Now
Financials
Companies that provide financial services to business or retail customers. The Financials theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for MediciNova Stock Analysis
When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.